Physician profile
Karl Freydl
NPI 1720183353
$4,588.74
in general payments reported to CMS, 2019-2025
13 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $244 · 2021: $275 · 2022: $1,182 · 2023: $2,260 · 2024: $225 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,763 · Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,763.17 |
| Food and Beverage | $1,004.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,619.51 | 2021-2025 | General - Pain Management |
| Relievant Medsystems, INC. | $969.74 | 2022 | |
| Nevro Corp. | $351.30 | 2020-2024 | Senza |
| Nalu Medical, INC. | $114.41 | 2023-2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $111.37 | 2025 | Excelsius Gps |
| Vertiflex, INC. | $107.69 | 2019 | |
| Abbott Laboratories | $83.20 | 2019-2022 | |
| Painteq LLC | $76.62 | 2024 | Painteq |
| Spr Therapeutics, INC | $54.92 | 2023 | Sprint Pns System |
| Stryker Corporation | $47.61 | 2025 | Mild Device Kit |
| Averitas Pharma INC. | $19.30 | 2025 | Qutenza |
| Si-Bone, INC. | $17.64 | 2025 | |
| Medtronic, INC. | $15.43 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Freydl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.